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Activation Mechanism of the MAP Kinase ERK2
by Dual Phosphorylation
Bertram J. Canagarajah,* Andrei Khokhlatchev,² and Cobb, 1992; Robbins et al., 1993) leads to over
1000-fold activation of ERK1 and ERK2. Both covalentlyMelanie H. Cobb,² and Elizabeth J. Goldsmith*³
bound phosphates are required to maintain high activity*Department of Biochemistry
(Seger et al., 1992; Robbins et al., 1993); activity is lost²Department of Pharmacology
through the action of serine/threonine phosphatases,The University of Texas Southwestern
tyrosine phosphatases (Anderson et al., 1990; BoultonMedical Center at Dallas
and Cobb, 1991), or dual specificity phosphatases (SunDallas, Texas 75235-9050
et al., 1993; Zheng and Guan, 1993). Also, replacement
of Thr-183 by alanine or Tyr-185 by phenylalanine abol-
ishes the activity of ERK1 or ERK2 (Robbins et al., 1993).Summary
Mutation of the phosphorylated residues to glutamate
does not yield a constitutively active MAP kinase, as isThe structure of the active form of the MAP kinase
the case for some protein kinases (Mansour et al., 1994).ERK2 has been solved, phosphorylated on a threonine
Glutamate can substitute for phosphothreonine, how-and a tyrosine residue within the phosphorylation lip.
ever, once tyrosine is phosphorylated, to give an activeThe lip is refolded, bringing the phosphothreonine and
enzyme in the mutant ERK2/T183E (Robbins et al., 1993;phosphotyrosine into alignment with surface arginine-
Zhang et al., 1995) with 10% the activity of wild type.rich binding sites. Conformational changes occur in
Thus, glutamate is a mimic for phosphothreonine butthe lip and neighboring structures, including the P11
not for phosphotyrosine in ERK2.site, the MAP kinase insertion, the C-terminal exten-
Crystallographic analysis of the cyclic AMP-depen-sion, and helix C. Domain rotation and remodeling of
dent protein kinase (cAPK; Knighton et al., 1991a, 1991b)the proline-directed P11 specificity pocket account
and subsequently other protein kinases (Knighton et al.,for the activation. The conformation of the P11 pocket
1991a; Goldsmith and Cobb, 1994; Owen et al., 1995;is similar to a second proline-directed kinase, CDK2-
Xu et al., 1995; Johnson et al., 1996; Longenecker etCyclinA, thus permitting the origin of this specificity
al., 1996; Russo et al., 1996) has defined the essentialto be defined. Conformational changes outside the lip
features of a core common to all protein kinases. Theprovide loci at which the state of phosphorylation can
core has two domains, and the active site is found atbe felt by other cellular components.
the domain interface. ATP binds deep in the active site
cleft, and a peptide substrate binding groove has beenIntroduction
observed in cAPK (Knighton et al., 1991b) and twitchin
(a myosin light-chain kinase homolog; Hu et al., 1994)MAP (mitogen-activated protein) kinases are central
that lies on the surface of the C-terminal domain. Thetransducers of extracellular signals from hormones,
substrate phosphoacceptor binds near the ªcatalyticgrowth factors, cytokines, and environmental stresses.
loop,º the locus of several conserved residues. The P11
The MAP kinase isoforms ERK1 and ERK2 (extracellular
residue of substrate binds to a surface pocket in the
signal-regulated protein kinases; Boulton et al., 1990,
C-terminal domain (Figure 1). Several protein kinases
1991) mediate key events throughout the cell and phos-
(Johnson et al., 1996) have phosphorylation sites in a
phorylate transcription factors (Chenget al., 1993; Gupta
surface loop, referred to as the ªactivation loopº or ªlip,º
and Davis, 1994), cytoskeletal proteins, and other pro-
that is contiguous with the P11 site. Thr-183 in ERK2
tein kinases and enzymes (Davis, 1993; Seger and Krebs,
is homologous toa threonine phosphorylation site found
1995). Mammalian MAP kinase family members number in other protein kinases. However, the tyrosine phos-
over a dozen and include p38/HOG1 (Han et al., 1994),
phorylation site, Tyr-185 in ERK2, is unique to MAP ki-
the c-Jun N-terminal kinase stress-activated protein ki-
nases. Several protein kinases have autoinhibitory do-
nases (JNK/SAPK; DeÂ rijard et al., 1994; Kyriakis et al., mains, as is the case for the tyrosine kinase c-Src (Xu
1994), and ERK5/BMK1 (Lee et al., 1995; Zhou et al., et al., 1997) and twitchin (Hu et al., 1994). Others are
1995). Each MAP kinase is activated by a cascade of inhibited (Su et al., 1995) or activated (Russo et al., 1996)
protein kinases comprising a MAP/ERK kinase (MEK; by separate polypeptides. In contrast, ERK2 is regulated
Mansour et al., 1994; Robinson et al., 1996a) and a MAP/ solely by dual phosphorylation.
ERK kinase kinase (MEKK; Dent et al., 1992; Kyriakis et MAP kinases are proline directed; they phosphorylate
al., 1992; Cobb and Goldsmith, 1995). Similarly, each only substrates that contain proline in the P11 site
MAP kinase phosphorylates a distinct spectrum of cellu- (Clark-Lewis et al., 1991; Songyang et al., 1994, 1996).
lar substrates (Brunet and PouysseÂ gur, 1996; Kyriakis Sequences forming the P11 specificity region comprise
and Avruch, 1996). Thus, although these enzymes are 185YVATRWYR192 (ERK2 numbering) and are highly con-
related, they are highly specific in their interactions with served in the MAP kinases and the cyclin-dependent
both activating enzymes and substrates. protein kinases (CDKs; Russo et al., 1996), a second
The activity of MAP kinases is tightly controlled by family of proline-directed kinases. However, MAP ki-
dual phosphorylation. Phosphorylation of Thr-183 and nases bind short proline-containing peptides relatively
Tyr-185 (Ahn et al., 1991; Payne et al., 1991; Robbins poorly (Haycock et al., 1992; Robinson et al., 1996b).
Analysis of both MAP kinases (Fu et al., 1994; Kallunki
et al., 1994) and their substrates (Cheng et al., 1993;³To whom correspondence should be addressed.
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Figure 1. Low-Activity and Doubly Phosphorylated ERK2
Ribbon diagram of (A) ERK2 and (B) ERK2-P2. The N-terminal domain (residues 1±109 and 320±358) is formed largely of b strands (green)
and two helices, C (blue) and aL16 (magenta). The C-terminal domain (residues 110±319) is mostly helical (blue), contains the phosphorylation
lip (red) and the MAP kinase insertion (magenta, labeled MKI), and is the locus of the P11 site, the catalytic loop (residues Arg-147±152,
labeled C loop). The side chains of Thr-183, Tyr-185, pTyr-183, and pTyr-185 are shown. The images were drawn using MOLSCRIPT (Kraulis,
1991) and rendered using RASTER3D (Bacon and Anderson, 1988).
(C) Superposition of ERK2 (green and gold) and ERK2-P2 (blue and red) using corresponding Ca atoms within the C-terminal domain (residues
109±171, 205±245, 272±310), drawn using SETOR (Evans, 1993). The molecules have been rotated by about 908 about the vertical axis relative
(A) and (B) to show domain rotation and closure. Refolded segments are highlighted in red and gold, respectively.
Hibi et al., 1993; Livingstone et al., 1995) by mutagenesis ERK2. Crystallographic analysis of phosphorylation site
mutants (Zhang et al., 1995) revealed that fifteen resi-suggests that substrate residues N-terminal to the phos-
phoacceptor site bind to the C-terminal domain of the dues in the lip (Val-171-Tyr-185) and other residues in
nearby loops are disordered if Tyr-185 is substituted bykinase in a peptide substrate binding groove which is
similar to that observed in other kinases (Knighton et glutamate. Therefore, the stability of the lip is low, and
it may change conformation upon activation and MEKal., 1991b; Hu et al., 1994).
Unphosphorylated ERK2 (Figure 1; Goldsmith and binding. The structure of p38, a second MAP kinase,
has been determined in its unphosphorylated form (Wil-Cobb, 1994; Zhang et al., 1994, 1995) is a compact 42
kDa protein kinase, topologically similar to cAPK. MAP son et al., 1996; Wang et al., 1997), showing that the
conformation of the lip is different in different MAP ki-kinases are distinguished from other members of the
protein kinase family by a 50-residue insertion (MAP nases.
Here we describe the crystal structure of the doublykinase insertion) between helices G and H defined in
cAPK (Figure 1) and by an extended C terminus (L16) phosphorylated form of ERK2 (ERK-P2) at 2.4 AÊ resolu-
tion. We observe the action of a compact regulatorythat spans both domains and terminatesas a helix, aL16.
The two domains that form the kinase core of ERK2 are sequence, the lip, that simultaneously remolds the ac-
tive site and P11 specificity pocket. Further, conforma-rotated apart relative to their orientation in the structure
of cAPK. Therefore, the catalytic residues are mis- tional changes in the neighboring MAP kinase insertion
and L16 occur that may account for phosphorylation-aligned, possibly contributing to the low activity of the
unphosphorylated enzyme. Furthermore, the P11 spec- specific interactions with substrates, upstream en-
zymes, and other cellular components. The structure ofificity region, which isonly a surface depression in ERK2,
is apparently blocked, so that access of substrates to the substrate P11 binding site of ERK2-P2 is similar
to that of active CDK2-CyclinA, suggesting a commonthe active site may be regulated by phosphorylation.
The phosphorylation site residues Thr-183 and Tyr-185 mechanism for proline recognition (Russo et al., 1996).
The conformational changes observed suggest that theare found in the lip, where Tyr-185 is buried in low-
activity ERK2. Two clusters of positively charged resi- tight control by dual phosphorylation and specificity for
proline are linked properties of MAP kinases.dues are near the lip. One cluster is conserved among
MAP kinases and ligates phosphothreonine (Johnson et
al., 1996; Russo et al., 1996) in other enzymes. A second Results
cluster, in the P11 site, binds a sulfate of crystallization
in ERK2 (Zhang et al., 1995) and is unique to the MAP Phosphorylated ERK2 was obtained by coexpression of
ERK2 and MEK1 encoded on a single plasmid in E. colikinases. However, neither Thr-183 nor Tyr-185 is aligned
with these charges in the structure of unphosphorylated (Mansour et al., 1994; Khokhlatchev et al., 1997). ERK2
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Figure 2. Electron Density for pThr and pTyr
Electron density map, in the vicinity of the
phosphorylation lip and the P11 specificity
pocket of ERK2-P2, contoured at 1.2s and
drawn in O (Jones and Kjeldgaard, 1993). The
map was calculated in X-PLOR (BruÈnger,
1992) using coefficients 2|Fo|-|Fc| and model-
derived phases for diffraction data between
20 and 2.4 AÊ . The map corresponding to Gly-
180-Thr-188 is yellow; phosphate atoms are
green, and ordered water molecules are red
spheres.
obtained from this system is fully active, and this activity also interacts indirectly with Arg-65 in helix C via a water
molecule. In total, pThr-183-PO4 makes eight hydrogenis reduced by exposure to phosphoprotein phosphatase
2A and the phosphotyrosine phosphatase PTP1, as ex- bonds or ionic contacts. pThr-183 is further the focus
of two extended networks of hydrogen bonds and ionicpected. Crystals of ERK2-P2 are obtained under differ-
ent conditions than those used to crystallize ERK2, and interactions that unite residues in the lip with helix C in
the N-terminal domain and with the C-terminal extensionthe crystals form into a different space group (Experi-
mental Procedures). The structure was solved by molec- L16 (between residues Lys-328 and Asp-335). Through
these interactions with the N-terminal domain and L16,ular replacement using the structure of low-activity
ERK2 as a search model with X-ray diffraction data to pThr-183 directly influences the orientation of the do-
mains as discussed below.2.4 AÊ resolution and was refined to an overall Rfree of
26.4%. The present model of ERK2-P2 contains 352 of Tyrosine 185 is buried and inaccessible to solvent in
the structure of unphosphorylated ERK2 (Zhang et al.,the 358 residues in the protein (excluding the His6-tag),
102 water molecules, and two covalently bound phos- 1994). Upon phosphorylation, rotation around the back-
bone atoms of Tyr-185 moves its side chain to the sur-phate ions (pThr-183-PO4 and pTyr-185-PO4; Figure 1B).
In ERK2-P2, 324 residues occupy positions correspond- face of the enzyme where, along with residues Val-186
to Arg-192, it formspart of thesubstrate P11recognitioning to those found in ERK2 (as defined by local move-
ment of less than 2 AÊ ). The Ca atoms of these residues site. As with pThr-183, pTyr-185 is ligated by arginine
residues Arg-189 and Arg-192. These arginines form anin ERK2 and ERK2-P2 superimpose with an rms (root-
mean-square) deviation of 1.1 AÊ . The N- and C-terminal anion binding site observed in low-activity ERK2 (Zhang
et al., 1995). In contrast to pThr-183, pTyr-185 formsdomains superimpose better individually, with rms devi-
ations of 0.8 AÊ and 0.5 AÊ , respectively. The two domains only four interactions, with Arg-189Nh, Arg-189Nj2, Arg-
192Nj1, and Arg-192Nj2, and is largely exposed to sol-are rotated toward one another in ERK2-P2 by 5.48
(Figure 1C). vent (Figure 3B). The pocket Tyr-185 occupies in the
low-activity structure is filled by Val-186 in ERK2-P2.
As discussed in detail below, the binding of pTyr-185Structural Consequences of Threonine
and Tyrosine Phosphorylation promotes conformational changes in the P11 site likely
to be necessary for substrate recognition.Upon phosphorylation, pThr-183 forms ionic contacts
with the N-terminal domain, thereby promoting domain To bring the phosphorylation site residues into align-
ment with their arginine-rich surface binding sites, theclosure, and pTyr-185 ispositioned to participate insub-
strate recognition. The covalently bound phosphates lip in ERK2-P2 is completely refolded (Figures 1 and 4)
between Gly-167 (in the conserved DFG sequence) andare clearly visible in the electron density (Figure 2). In
ERK2-P2, phosphothreonine-183 (pThr-183) interacts pTyr-185. pThr-183 moves 9 AÊ , and Phe-181 undergoes
the largest displacement of 15 AÊ . The conformationaldirectly with three arginine residues, Arg-68 in helix C,
Arg-146 in the catalytic loop (Arg-165 in cAPK; Knighton changes extend from the lip into the P11 recognition
site through Ala-187. In ERK2, the phosphorylation lipet al., 1991a), and Arg-170 in the lip (Figure 3A). pThr-183
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Figure 3. Stereo Diagram of the Environment of pThr and pTyr
(A) Stereodiagram showing interactions of pThr-183 in ERK2-P2. Two hydrogen bonding networks emanate from pThr-183. In one network,
the pThr-183 ligand Arg-68 is hydrogen bonded to Asp-334 in L16, which also interacts with Gln-64 in helix C. In a second network, pThr-
183 ligand Arg-170 interacts with Glu-332 in L16 and His-178 in the lip. Arg-146 forms a hydrogen bond with Tyr-203 (an interaction is present
in other protein kinases [Zhang et al., 1995]). The water molecules interacting with pThr-183 are shown as cyan spheres.
(B) Stereodiagram showing interactions of pTyr-185 in ERK2-P2 and the environment of the P11 site.
is wrapped around the side chains of Lys-201 and the lip, forming the core, with Tyr-203, around which the
lip is packed. The lip is also completely remodeled atTyr-203 in the neighboring surface loop, defined by resi-
dues 199±205 (Loop199±205, Figure 4A) (Zhang et al., its N terminus, making interactions with L16 described
below.1995), and the lip and Loop199±205 are knit together
through backbone interactions. In ERK-P2, these back-
bone interactions are lost. Instead, the lip is threaded Changes in Structure and Interactions in the
C-Terminal Extension L16 and thebetween Lys-201, which faces solvent, and Tyr-203,
which remains partially buried (Figure 4B); between resi- MAP Kinase Insertion
New contacts between L16 and the lip and the formationdues Gly-180 and Glu-184, the backbone of the lip is
wrapped around Lys-201. Ala-187 adopts a left-handed of a 3/10 helix in L16 in ERK2-P2 promote tighter in-
teractions between the two domains. L16 (Pro-309 to(defined as w . 0) conformation (w 5 708, c 5 1588) in
ERK2-P2 and Gly-180 is also left-handed. Leu-182, Arg-358) is the C-terminal extension following the con-
served protein kinase core (Zhang et al., 1994; Hankswhich is left-handed in ERK2, becomes right-handed
(w 5 2958) in ERK2-P2. Phe-181 and Leu-182 in the lip and Hunter, 1995). Pro-309 and Leu-336 in L16 occupy
a surface groove at the domain interface between heli-form a hydrophobic patch that tethers the top of the
MAP kinase insertion to the lip (Figure 4A). In ERK2-P2, ces C and E and near the lip. L16 crosses into the
N-terminal domain forming aL16 (Figure 1). In ERK2-P2,Phe-181 moves 15 AÊ and is left facing solvent in ERK2-
P2 (Figure 4B), while Leu-182 becomes buried beneath residues in L16 participate in two hydrogen bonding
Structure of Active ERK2
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Figure 4. Changes in the Interaction between the Phosphorylation Lip and the Neighboring Structures
Interactions of the lip with loops 199±205, L16, and MAP kinase insertion in (A) ERK2 and (B) ERK2-P2 drawn using SETOR. The color scheme
is the same as in Figure 1. Note that the lip takes a completely different path in ERK2-P2.
networks emanating from pThr-183, as noted above and walled on one side by a short helix (a1L12; Figure
1A). The same structures are present in ERK2; a loop(Figures 3A and 4B). A separate cluster of charges, be-
tween Asp-173, Asp-175, and Lys-328, further link the extends from pTyr-185 to Arg-189, and a1L12 from
Arg-189 to Arg-192 (Figure 3B). As described previouslylip with L16. In ERK2-P2, a new 3/10 helix is formed in
L16 between residues Phe-327 and Leu-333. Phe-329 (Zhang et al., 1994), the side chain of Arg-192 fills the
P11 site, excluding substrate side chains from bindingis buried against helix C in ERK2, but as part of the 3/10
helix in ERK2-P2, Phe-329 is on the surface and forms there. In ERK2, the P11 pocket is further blocked by
Val-186 (Figure 4A). In ERK2-P2, pTyr-185 binds directlya stacking interaction with His-176 in the lip. Met-331 fills
the pocket left by Phe-329, moving 7 AÊ upon formationof to Arg-189 and Arg-192 and appears to be positioned
to bind to substrate proline. The side chains of Val-186the 3/10 helix. In ERK2-P2, three leucine residues, Leu-
333, Leu-336 (shown in Figure 5), and Leu-344, in L16 and Ala-187 rotate into the structure, and the carbonyls
of both Val-186 and Ala-187 form hydrogen bonds withbecome more solvent-exposed than in ERK2 and form
an isologous lattice contact with a symmetry-related Arg-192, fully closing off the P11 site (Figure 3B).
Ala-187 assumes a left-handed configuration (w 5 708)molecule discussed further below. The conformational
changes in L16 are coordinate with shifts in position of in making these interactions. In ERK2-P2, in addition,
the rim of the P11 site becomes knit to the catalytichelix C (Figures 1C and 5).
Changes in the lip in ERK2-P2 lead to disorder in the loop with hydrogen bonds between Arg-146O and Ala-
187N and between Asp-147Od1 (the putative catalyticMAP kinase insertion. In ERK2, the lip interacts with
residues in the MAP kinase insertion and helix G (Figures base) and Thr-188N. Through these interactions, in addi-
tion to the bonds formed with Arg-192, the hydrogen1A and 4A). This interaction is lost as the lip is refolded
in ERK2-P2. Leu-181 and Phe-182 in the lip, which form bonding capacity of Val-186 and Ala-187 is nearly com-
pletely absorbed. In contrast, the backbone atoms pTyr-the contact in ERK2, undergo the most dramatic confor-
mational changes in the structure associated with acti- 185O and Arg-189N face solvent and are potentially
available for interactions with the backbone of substratevation, and Leu-182 becomes buried beneath the lip.
The MAP kinase insertion does not change conformation on either side of P11. As a consequence of phosphory-
lation, the P11 binding site forms a slightly deeper sur-significantly but does become more mobile between
Pro-245 to Pro-266. The effect is particularly pro- face depression (Figure 6A) that is similar to that of
active CDK2 (Jeffrey et al., 1995; Russo et al., 1996).nounced on Arg-259, which in the low-activity structure
lies in the surface groove between a1L14 and a2L14,
but on activation is disordered. Ile-254, which forms the Origin of Specificity for Proline in the P11 Site
MAP kinases only phosphorylate substrates containingcontact between the MAP kinase insertion and the lip
in the low-activity structure, is left exposed to solvent proline in the P11 site (Songyang et al., 1996). In con-
trast, other serine/threonine kinases such as cAPKin ERK2-P2 and is also disordered.
(Songyang et al., 1994) exclude substrates with proline
in P11 (Figure 6C). We speculate that the unique hydro-Conformational Changes Promote Substrate
Recognition in the P11 Site gen-bonding properties of proline-containing peptides
may account for this discrimination. Only four prolineThe P11 specificity site undergoes conformational
changes on activation that are likely to be important for conformations are observed in proteins (MacArthur and
Thornton, 1991): two trans-proline conformations (w 5substrate recognition. The position of the P11 site is
known by homology with cAPK (Knighton et al., 1991b) 2608, c 5 2358; w 5 2608, c 5 1508) and two cis-proline
conformations (w 5 2868, c 5 18; w 5 2768, c 5 1598).and is formed by a surface loop contiguous with the lip
Cell
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Figure 5. Conformational Changes in the N-Terminal Domain
Helix C (blue), L16 (magenta), and the phosphate binding ribbon (green) in (A) ERK2 and (B) ERK2-P2. Residues that form contacts between
these segments are displayed, as are Leu-333 and Leu-336, which form a dimer interface.
The backbone conformation of the residue-preceding conformations, (w 5 2608, c 5 1508) may be preferred
because it permits interactions between the carbonylproline is also somewhat restricted, to values near (w 5
2908, c 5 1358). To understand why ERK2 specifically oxygen of pTyr-185 and the backbone nitrogen atom of
the P11 residue of substrate (Figure 6B). The modelbinds substrates with proline at P11, we modeled the
ERK2-P2 complex with Thr-Pro-Ala peptide in which the suggests that pTyr-185 is directly involved in proline
recognition. Further, although there are hydrogen bond-central proline was constrained to each of the above
four conformations. The position of the threonine hy- ing possibilities for substrate residues on either side of
the P11 site, ERK2-P2 offers no potential hydrogendroxyl was estimated from a water molecule observed
bound to the catalytic base Asp-147. The modeling sug- bond acceptors for the P11 residue of the substrate.
Consequently, for residues other than proline, bindinggests that the site can bind to trans- but not cis-proline.
Cis-proline is excluded because it would project into to ERK2-P2 would impose an energetic cost from not
forming backbone interactionsat P11. Further, as notedsolvent (not shown). Trans-proline can bind in the sur-
face depression formed by the side chain of pTyr-185, above, larger amino acids would be excluded from the
P11 binding site because of the pocket blocked bythe side chain of Leu-168 (Figure 6B), and the backbone
of pTyr-185 to Ala-187. Of the accessible trans-proline Arg-192 (Figures 3B and 6B). Finally, small residues such
Figure 6. Substrate Binding Site
The surface representation of the P11 speci-
ficity pocket of (A) ERK2, (B) ERK2-P2, and
(C) cAPK (Protein Data Bank file 1ATP) drawn
using GRASP (Nicholls et al., 1991). Interac-
tion between the substrate and ERK2-P2 at
the P11 site is modeled using a Thr-Pro di-
peptide.
(D) Surface of ERK2 calculated in GRASP and
rendered in RASTER3D.
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as glycine and possibly alanine may be excluded be- a 2-fold symmetric contact. Residues involved in the
interaction are Leu-333, Leu-336 (Figure 5), and Leu-344.cause their greater flexibility would allow them to adopt
a conformation not available to proline and bind in a Surprisingly, these leucine residues are exposed on the
surface of the monomer in both ERK2 and ERK2-P2.mode that is nonproductive for catalysis.
However, they move considerably with the major confor-
mational changes in L16 and lock together as a hy-Access to the Extended Substrate Binding
drophobic zipper in ERK2-P2. A total of 1470 AÊ 2 of theGroove Is Not Regulated
dimer is buried in the interaction. The two active sitesby Phosphorylation
are on the same face of the dimer and accessible toThe extended peptide substrate binding groove defined
solvent.in cAPK (Knighton et al., 1991a) and in twitchin (Hu et
In a second lattice contact, three residues at the Cal., 1994) (Figure 6D) does not change shape on phos-
terminus (Tyr-356 to Ser-358) bind in the active site ofphorylation. The binding groove lies between helices D
a neighboring molecule, where Arg-357 in the C terminusand G in the C-terminal domain. The Karin laboratory
makes an ion pair with Asp-165 in the active site ofhas shown that specificity in the ERK2 homolog JNK2
another molecule (data not shown). The domain struc-is directed by sequences in L13, which links helices F
ture and conformation of the phosphate binding ribbonand G, and thus may bind substrates in this locus (Kal-
resemble CDK2, suggesting that this lattice interactionlunki et al., 1994). Superposition of the C-terminal do-
has not introduced serious artifacts. The closed confor-mains of ERK2 and ERK2-P2 shows that they are similar,
mation of the phosphate binding ribbon observed heresuperimposing with an rms deviation of only 0.5 AÊ (Fig-
is somewhat similar to that observed in other kinasesure 1C). Thus, other than the changes in the lip and P11
when bound by ATP.specificity pocket, there are relatively few conforma-
tional changes in this domain on phosphorylation. How-
ever, Tyr-231 in L13, which makes two hydrogen bonds
Discussionwith the lip in ERK2 (Figure 4), becomes disordered in
ERK2-P2. Also, an increase in mobility is observed in
MAP kinases are compact enzymes lacking in regulatorythe MAP kinase insertion, which is adjacent to helix G.
domains, autoinhibitory segments, or regulatory sub-Overall, the lack of conformational changes in ERK2-P2
units. Nevertheless, they are highly specific in their inter-in the peptide binding groove suggests that this region
actions with substrates and activating enzymes, andis not involved in the regulation of ERK2. Further, the
their activity is tightly controlled. The control of activitysubstrates may bind to this site independent of the state
depends on refolding of the phosphorylation lip near theof phosphorylation.
active site, thereby bringing the two covalently bound
phosphates, pThr-183 and pTyr-185, into alignment with
Formation of the Catalytic Site surface phosphate binding sites. pThr-183 moves 9 AÊ to
Upon phosphorylation, the N- and C-terminal domains occupy a site in the domain interface, thereby promoting
of ERK2-P2 rotate toward each other, thereby organiz- domain closure. In ERK2-P2, the rigid body domain rota-
ing catalytic residues in the active site (Figures 1C and tion is slight, only 58, but results in improved active site
5). Catalytic residues are clustered in the catalytic loop stereochemistry. A large backbone rotation brings pTyr-
and DFG sequence from Asp-147 to Asp-165 (Asp-184 in 185 onto the surface where it binds and forms the pro-
cAPK) in the C-terminal domain. The N-terminal domain line-directed P11 specificity site. The refolding of the lip
contributes the glycine-rich phosphate binding ribbon, also produces conformational changes in neighboring
formed by the first two strands of the N-terminal domain surface loops that may mediate phosphorylation-
b-sheet, and Lys-52, which is known to be essential dependent interactions with other macromolecules and
for catalysis (Robinson et al., 1996b). Domain rotation self-association.
brings Lys-52 and the phosphate binding ribbon closer pThr-183 improves the geometry in the active site.
to Asp-147 and Asp-165 in the C-terminal domain. The pThr-183 is the focus of twohydrogen bonding networks
ribbon twists relative to the rest of the N-terminaldomain that connect the lip to the N-terminal domain. One net-
b sheet. Also, Glu-31 through Tyr-34 at the reverse turn work links pThr-183 to L16, a few residues of which
of the ribbon are disordered in ERK2 but become local- shorten into a 3/10 helix in ERK2-P2. A second network
ized in ERK2-P2 through interactions with Tyr-62 in helix brings pThr-183 in contact with helix C. The conforma-
C. The rigid geometry of the phosphate binding ribbon tional changes in helix C improve the interaction be-
appears to be promoted by a change in position of helix tween the conserved catalytic residues Lys-52 and Glu-
C and L16 (Figure 5) relative to the rest of the domain, 69 (in helix C) and facilitate localization of the phosphate
owing to the ion pair interactions formed by Arg-65 and binding ribbon. The structural changes in helix C and
Arg-68 of helix C with pThr-183 (Figures 1C, 3A, and 4B) L16 are linked through numerous interactions. The do-
in ERK2-P2. The shift in position of helix C also brings mains of ERK2-P2 are not as tightly closed as they are
Glu-69 closer to Lys-52 to form a 3 AÊ ion pair in ERK2-P2. in the ternary complex observed in cAPK. However, the
structural changes in the N-terminal domain, particularly
in helix C, compensate and bring catalytic residues intoDimers of ERK2-P2
Phosphorylated ERK2 forms dimers in the crystals used alignment (Figures 1C and 5). Comparison of the low-
activity structures of ERK2 and the MAP kinase p38in this analysis. The monomers of the dimer are related
by a crystallographic 2-fold axis that brings L16 from suggests that domain rotation and remodeling of helix
C will occur upon activation of p38 as well, althoughtwo neighboring molecules in close proximity to form
Cell
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the direction of movement of helix C should differ. The containing N-terminal sequences through helix C de-
rived from p38 have relaxed upstream specificity. Struc-environment of pThr-183 in ERK2-P2 is similar to that of
tural differences between p38 and ERK2 are particularlypThr-160 in phosphorylated CDK2/CyclinA, where two
large at the N terminus of helix C where it interacts withhydrogen bonding networks are also observed. In CDK2,
L16 and thus might direct pathway-specific interactions.one network is linked to helix C, as in ERK2. The second
Although no interactions are known to be mediated bynetwork, corresponding to that connected to L16 in
the MAP kinase insertion, a homologous structure inERK2, bonds CyclinA to CDK2. In this sense, L16 per-
CDK2 binds to a cell cycle±regulated protein (of un-forms a similar function in ERK2 as CyclinA performs in
known function) CksHs1 (Bourne et al., 1996). CellularCDK2-CyclinA complexes. As with ERK2, reorientation
components that might interact with ERK2 in a phos-of helix C is a major feature in the activation of CDK2
phorylation-dependent fashion are signaling complexes(Jeffrey et al., 1995), where rotation of helix C forms the
and nuclear localization and export machinery. It is an-active site Lys-33±Glu-51 ion pair (homologous to Lys-
ticipated that these latter interactions are likely to be52±Glu-69 in ERK2) in response to CyclinA binding
mediated by the segments that undergo conformational(Russo et al., 1996). Rotation of helix C may contribute
changes in ERK2-P2.to the activation of the tyrosine kinase Hck (Xu et al.,
In contrast to the P11 recognition site and the struc-1997) as well. In ERK2-P2, the changes in helix C are
tures near the phosphorylation lip, the extended sub-coordinate with changes in L16 and are a direct conse-
strate binding groove is not modified in ERK2-P2. Thequence of phosphorylation.
Karin laboratory has shown in JNK2/JNK1 chimeras thatpTyr-185 forms the proline-directed P11 specificity
specificity toward c-Jun is directed to the same regionpocket. A slightly deeper surface depression is apparent
of the structure as the peptide substrate binding groovein ERK2-P2 than in ERK2. The P11 pockets of ERK2-
identified in cAPK (Hibi et al., 1993). They have alsoP2 and active CDK2 are similar (Jeffrey et al., 1995;
shown that JunB, a c-Jun homolog which cannot beRusso et al., 1996): the backbone structure is similar,
phosphorylated, can bind to the MAP kinase JNK2 (Hibiand both have an arginine residue filling the P11 pocket.
et al., 1993). Our results suggest, to the extent that JNKsHowever, CDK2 lacks phosphotyrosine. In contrast, the
are similar to ERKs, that molecules such as JunB shouldlow-activity conformations of ERK2 and CDK2 are com-
bind to their cognate MAP kinase independent of thepletely different (De Bondt et al., 1993; Zhang et al.,
state of phosphorylation.1994). This suggests that the conformation observed in
MAP kinases are resistant to activating point muta-the active structures recognizes proline. Our modeling
tions, and there are no known associated oncogenes.experiment suggests that proline can bind to the P11
Replacement of either or both phosphorylation site resi-site of ERK2-P2 ina standard trans-proline conformation
dues by negatively charged amino acids does not lead(w 5 2708, c 5 1508; MacArthur and Thornton, 1991).
to activation nor does deletion of the C terminus (Wils-Large residues other than proline are excluded because
bacher and Cobb, unpublished data). The requirementthere is no place for the side chain. Small nonproline
for added interactions in the P11 site to stabilizeresidues are excluded because the enzyme cannot ac-
Ala-187, a glycine in other protein kinase families, maycept a hydrogen bond from the main chain amide of the
serve to prevent undesired activation of the MAP ki-P11 residue. Alternatively, small residues might bind but
nases. This ªpositive regulationº is quite rare. Most pro-assume a nonproductive binding mode. Proline versus
tein kinases (Goldsmith and Cobb, 1994), as well asnonproline specificity in P11 appear to be mutually ex-
allosteric proteins generally (Monod et al., 1965; Gold-clusive properties of protein kinases (Songyang et al.,
smith, 1996), are regulated by inhibitory or autoinhib-1996). Thus, the proline-directed feature of MAP kinases
itory mechanisms. cAPK (Knighton et al., 1991b; Su et
and CDKs make them especiallyselective. The remodel-
al., 1995), twitchin kinases (Hu et al., 1994) and other
ing of the P11 site involves formation of an energetically
MLCKs, and Ca21-calmodulin dependent kinase (Ohashi
unfavorable conformation for Ala-187 with w 5 708.
et al., 1994) are each inhibited by other subunits or ªin-
As the lip is refolded in ERK2-P2, the lip loses contact trastericº polypeptide segments that bind in the peptide
with the MAP kinase insertion and gains an interaction substrate binding groove. Src family tyrosine kinases
with L16. As a consequence, the MAP kinase insert (Sicheri et al., 1997; Xu et al., 1997) are also regulated
becomes partially disordered. L16 undergoes more ex- by autoinhibition through their SH2 and SH3 domains.
tensive changes as a new 3/10 helix is formed in L16, Many of the tyrosine kinases (Hunter, 1987), as well as
affecting the interactions with helix C and promoting Raf (Stanton and Cooper, 1987) and others (Mansour
dimer formation. These regions are disordered in un- et al., 1994), can be activated by point mutations and
phosphorylated ERK2 when Tyr-185 is substituted by deletions. The MAP kinases cannot. The structures of
other amino acids, especially glutamate (Zhang et al., active and inactive ERK2 suggests that ERK2 adopts
1995). Apparently these segments are marginally stable a different regulatory paradigm in which activation
in ERK2 and are poised for conformational change. The requires formation of an energetically unfavorable
structural changes in the MAP kinase insertion L16 and structure.
helix C can potentially mediate phosphorylation-depen- In conclusion, the phosphorylation lip works as a cen-
dent interactions with other macromolecules. It is not tral regulator of ERK2. In the low-activity structure, the
known whether interactions with MEK1 and -2 are de- lip is folded toblock the P11 site and forces the domains
pendent on the phosphorylation state. However, helix into an open structure. On phosphorylation, a new ar-
C has been implicated in MEK interactions. Brunet and rangement of the lip promotes domain closure, forma-
tion of the proline-directedP11 site, and conformationalPouysseÂ gur (1996) have shown that p38/ERK chimeras
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7.9%, 105,306 total reflections, 16,537 unique reflections, averagechanges in neighboring segments of the polypeptide
redundancy 6.4, <I/s> 5 27.0). Data in the outermost shell, fromchain. The latter include changes in L16, which promote
2.5 to 2.4 AÊ , was complete to 60.3% (Rsym 5 20.1%, 1070 uniquedomain closure as well as remodeling of phosphoryla-
reflections, <I/s> 5 8.0).Starting phases for ERK2-P2 were obtained
tion-dependent interactions with other macromole- by molecular replacement using coordinates of unphosphorylated
cules. The conformational changes in L16 also lead to ERK2 (PDB entry 1ERK) as the search model in the program AMoRe
(Navaza, 1994). The rotation function yielded an 8.1 s peak for dataformation of a tight dimer in crystals of ERK2-P2, which
between 9.0 and 3.5 AÊ . Of the two possible space groups, the trans-is likely to be physiologically important. The conforma-
lation search gave the best correlation in the enantiomorph P41212tions of the lip in ERK2 and ERK-P2 are exquisitely
of 0.45, compared to 0.31 in P43212, and an R factor of 42.2%.balanced energetically and are dependent on the two
The model was built into electron density maps calculated with
phosphorylation site residues. The multiple functions of coefficients 2|Fobs|-|Fcalc|, SigmaA weighted, and calculated by
the lip may contribute to the tight regulation of MAP REFMAC in CCP4 (Collaborative Computing Project, 1994). Cycles
of refinement were carried out in X-PLOR (BruÈ nger, 1992) usingkinases and the resistance of the enzyme to activating
6.0±2.4 AÊ data. In the final model, the N-terminal Ala-His-6 tag andpoint mutations.
the first six residues are missing, and the side chains for residues
181, 228±230, and 246±270 have only weak electron density. The
Experimental Procedures present R factor is 19.2 (Rfree 5 26.4%) for 15,364 reflections with
Fobs . 2s in the resolution range of 20±2.4 AÊ . Bulk solvent correction
Expression and Purification was applied at the final stage of refinement (k 5 0.41 and B 5 60.45
ERK2 was activated in vivo by coexpressing ERK2 and R4F, a consti- AÊ 2) (Levitzki and Gazit, 1995). The rms deviation from ideal bond
tutively active MEK1 (Khokhlatchev et al., 1997). Both ERK2 and R4F distance and bond angle are 0.01 AÊ and 1.3440, respectively. The
were subcloned into the same NpT7±5 plasmid used to transform peptide torsion angles for 351 out of 352 well-defined residues fall
competent BL21(DE3) E. coli cells. An overnight culture was grown within most favored or generally allowed regions of the Ramachan-
in 60 ml Terrific Broth (TB), 100 mg/ml ampicillin. Six liters of culture dran plot, as defined in the program PROCHECK (Laskowski et al.,
medium was inoculated, grown at 308C, and induced with 0.4 mM 1993). The single exception, Ala-187, was carefully checked in the
IPTG when OD600 5 0.8 was reached. Cultures were grown for 12 electron density map. The average B value for all protein atoms
to 16 hr after induction. The cells were flash frozen in liquid nitrogen is 26.3 AÊ 2. The present model includes 102 water molecules. The
and resuspended later in buffer (50 mM sodium phosphate [pH 8.0], coordinates have been deposited in the Protein Data Bank, acces-
and 300 mM NaCl). Cells were lysed in 1 mg/ml lysozyme and 0.3% sion number 2ERK.
NP-40 using gentle sonication. The cell lysate was clarified by cen-
trifugation at 100,000 g for 30 min at 48C. Ni-NTA agarose (Qiagen)
Acknowledgementsand a 20±200 mM imidazole gradient in 50 mM sodium phosphate
(pH 7.2), 300 mM NaCl were used to separate ERK2 and ERK2-P2
This research was supported by the NIH DK46993, the State offrom other cell components. ERK2 and ERK2-P2 were separated
Texas Technology Transfer Grant #003660±131, The Welch Founda-on MonoQ HR5/5 column (Pharmacia) and equilibrated with 20 mM
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